1
|
Siracusa LR, Park E, Liu E, Baker AJ. Prolonged loss of nuclear HMGB1 in neurons following modeled TBI and implications for long-term genetic health. Brain Res 2025; 1855:149559. [PMID: 40081516 DOI: 10.1016/j.brainres.2025.149559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2024] [Revised: 03/04/2025] [Accepted: 03/06/2025] [Indexed: 03/16/2025]
Abstract
Under normal physiological conditions high mobility group box protein 1 (HMGB1) stabilizes chromatin, controls transcription, and contributes to DNA repair. Cellular stress or injury results in HMGB1 release from the nucleus acting as a proinflammatory cytokine. The objective of this study was to characterize the temporal progression of nuclear HMGB1 loss up to one week following modeled TBI in 250 g male rats and correlate these changes with the response of DNA damage proteins. HMGB1 was present in the cytoplasm and absent from the nucleus of neurons within 6 h of injury. Quantitative immunohistochemistry and Western blot analysis showed a significant decrease in nuclear HMGB1 expression at 6 and 24 h post-injury compared to controls. Approximately 20 % of neurons were lacking nuclear HMGB1 expression at 7 days post-injury. Cells which were negative for nuclear HMGB1 expression labelled positive for HIF1α, PARP, and γH2AX, indicators of oxidative stress and DNA damage. Nuclear HIF1α expression was detected at 6 h after injury. Nuclear expression of HIF1α, PARP, and γH2AX was observed at 7 days post-injury, suggesting activation of oxidative stress response mechanisms and DNA damage repair pathways. The temporal changes in HMGB1 translocation in conjunction with expression of DNA damage markers suggest a relationship between injury-induced HMGB1 loss in neurons and subsequent DNA damage. These results highlight a potential injury response mechanism with long-term implications in relation to genetic health of surviving neurons.
Collapse
Affiliation(s)
- Laura R Siracusa
- Institute of Medical Sciences, University of Toronto, Toronto, Canada; St. Michael's Hospital, Unity Health Toronto, Canada.
| | - Eugene Park
- St. Michael's Hospital, Unity Health Toronto, Canada
| | - Elaine Liu
- St. Michael's Hospital, Unity Health Toronto, Canada
| | - Andrew J Baker
- Institute of Medical Sciences, University of Toronto, Toronto, Canada; St. Michael's Hospital, Unity Health Toronto, Canada; Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Canada
| |
Collapse
|
2
|
Locskai LF, Gill T, Tan SAW, Burton AH, Alyenbaawi H, Burton EA, Allison WT. A larval zebrafish model of traumatic brain injury: optimizing the dose of neurotrauma for discovery of treatments and aetiology. Biol Open 2025; 14:bio060601. [PMID: 39936823 PMCID: PMC11849975 DOI: 10.1242/bio.060601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2024] [Accepted: 07/15/2024] [Indexed: 02/13/2025] Open
Abstract
Traumatic brain injuries (TBI) are diverse with heterogeneous injury pathologies, which creates challenges for the clinical treatment and prevention of secondary pathologies such as post-traumatic epilepsy and subsequent dementias. To develop pharmacological strategies that treat TBI and prevent complications, animal models must capture the spectrum of TBI severity to better understand pathophysiological events that occur during and after injury. To address such issues, we improved upon our recent larval zebrafish TBI paradigm emphasizing titrating to different injury levels. We observed coordination between an increase in injury level and clinically relevant injury phenotypes including post-traumatic seizures (PTS) and tau aggregation. This preclinical TBI model is simple to implement, allows dosing of injury levels to model diverse pathologies, and can be scaled to medium- or high-throughput screening.
Collapse
Affiliation(s)
- Laszlo F. Locskai
- Department of Biological Sciences, University of Alberta, Edmonton AB, T6G 2E9, Canada
- Centre for Prions & Protein Folding Disease, University of Alberta, Edmonton AB, T6G 2M8, Canada
| | - Taylor Gill
- Department of Biological Sciences, University of Alberta, Edmonton AB, T6G 2E9, Canada
- Centre for Prions & Protein Folding Disease, University of Alberta, Edmonton AB, T6G 2M8, Canada
| | - Samantha A. W. Tan
- Department of Biological Sciences, University of Alberta, Edmonton AB, T6G 2E9, Canada
- Centre for Prions & Protein Folding Disease, University of Alberta, Edmonton AB, T6G 2M8, Canada
| | - Alexander H. Burton
- Departments of Chemical and Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA
- Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA
| | - Hadeel Alyenbaawi
- Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah 11952, Saudi Arabia
| | - Edward A. Burton
- Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA
- Geriatric Research, Education and Clinical Center, Pittsburgh VA Healthcare System, Pittsburgh, PA 15213, USA
| | - W. Ted Allison
- Department of Biological Sciences, University of Alberta, Edmonton AB, T6G 2E9, Canada
- Centre for Prions & Protein Folding Disease, University of Alberta, Edmonton AB, T6G 2M8, Canada
- Department of Medical Genetics, University of Alberta, Edmonton AB, T6G 2H7, Canada
| |
Collapse
|
3
|
Ilyin NP, Shevlyakov AD, Boyko GA, Moskalenko AM, Ikrin AN, Galstyan DS, Kolesnikova TO, Katolikova NV, Chekrygin SA, Lim LW, Yang L, De Abreu MS, Yenkoyan KB, Kalueff AV, Demin KA. Neurotranscriptomic and behavioral effects of ISRIB, and its therapeutic effects in the traumatic brain injury model in zebrafish. Brain Res 2025; 1848:149329. [PMID: 39537125 DOI: 10.1016/j.brainres.2024.149329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2024] [Revised: 10/05/2024] [Accepted: 11/09/2024] [Indexed: 11/16/2024]
Abstract
Traumatic brain injury (TBI) is a global medical concern and has a lasting impact on brain activity with high risks of mortality. Current treatments are inadequate for repairing damaged brain cells or correcting cognitive and behavioral disabilities in TBI patients. Mounting evidence links TBI to the activation of the Integrated Stress Response (ISR) signaling in the brain. A novel small molecule, ISRIB, is an effective inhibitor of the ISR pathway, offering potential advantages for brain health. Here, we investigated how ISRIB affects brain transcriptome and behavior in zebrafish TBI model evoked by telencephalic brain injury. Overall, while TBI diminished memory and social behavior in zebrafish, administering ISRIB post-injury markedly reduced these behavioral deficits, and modulated brain gene expression, rescuing TBI-activated pathways related to inflammation and brain cell development. Collectively, this supports the role of brain ISR in TBI, and suggests potential utility of ISRIB for the treatment of TBI-related states.
Collapse
Affiliation(s)
- Nikita P Ilyin
- Almazov National Medical Research Centre, St. Petersburg, Russia; Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia
| | - Anton D Shevlyakov
- Neurobiology Program, Sirius University of Science and Technology, Sochi, Russia
| | - Galina A Boyko
- Almazov National Medical Research Centre, St. Petersburg, Russia; Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia
| | | | - Aleksey N Ikrin
- Neurobiology Program, Sirius University of Science and Technology, Sochi, Russia
| | - David S Galstyan
- Almazov National Medical Research Centre, St. Petersburg, Russia; Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia
| | | | - Nataliia V Katolikova
- Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia
| | - Sergei A Chekrygin
- Core Facility Center "Center Bio-Bank", Saint Petersburg University, St. Petersburg, Russia
| | - Lee Wei Lim
- Department of Biociences and Bioinformatics, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China; Suzhou Key Municipal Laboratory of Neurobiology and Cell Signaling, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China
| | - LongEn Yang
- Department of Biociences and Bioinformatics, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China; Suzhou Key Municipal Laboratory of Neurobiology and Cell Signaling, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China
| | - Murilo S De Abreu
- Graduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil; Western Caspian University, Baku, Azerbaijan
| | - Konstantin B Yenkoyan
- Neuroscience Laboratory, Cobrain Center, M. Heratsi Yerevan State Medical University, Yerevan, Armenia; Biochemistry Department, M. Heratsi Yerevan State Medical University, Yerevan, Armenia
| | - Allan V Kalueff
- Almazov National Medical Research Centre, St. Petersburg, Russia; Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia; Department of Biociences and Bioinformatics, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China; Suzhou Key Municipal Laboratory of Neurobiology and Cell Signaling, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China.
| | - Konstantin A Demin
- Almazov National Medical Research Centre, St. Petersburg, Russia; Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
| |
Collapse
|
4
|
Kolesnikova TO, Prokhorenko NO, Amikishiev SV, Nikitin VS, Shevlyakov AD, Ikrin AN, Mukhamadeev RR, Buglinina AD, Apukhtin KV, Moskalenko AM, Ilyin NP, de Abreu MS, Demin KA, Kalueff AV. Differential effects of chronic unpredictable stress on behavioral and molecular (cortisol and microglia-related neurotranscriptomic) responses in adult leopard (leo) zebrafish. FISH PHYSIOLOGY AND BIOCHEMISTRY 2025; 51:30. [PMID: 39812898 DOI: 10.1007/s10695-024-01446-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/11/2024] [Accepted: 12/31/2024] [Indexed: 01/16/2025]
Abstract
Stress plays a key role in mental, neurological, endocrine, and immune disorders. The zebrafish (Danio rerio) is rapidly gaining popularity as s model organism in stress physiology and neuroscience research. Although the leopard (leo) fish are a common outbred zebrafish strain, their behavioral phenotypes and stress responses remain poorly characterized. Here, we examined the effects of a 5-week chronic unpredictable stress (CUS) exposure on adult leo zebrafish behavior, cortisol levels, and brain gene expression. Compared to their unstressed control leo counterparts, CUS-exposed fish showed paradoxically lower anxiety-like, but higher whole-body cortisol levels and altered expression of multiple pro- and anti-inflammatory brain genes. Taken together, these findings suggest that behavioral and physiological (endocrine and genomic) responses to CUS do differ across zebrafish strains. These findings add further complexity to systemic effects of chronic stress in vivo and also underscore the importance of considering the genetic background of zebrafish in stress research.
Collapse
Affiliation(s)
| | - Nikita O Prokhorenko
- Neurobiology Program, Sirius University of Science and Technology, Sochi, Russia
| | - Sahil V Amikishiev
- Neurobiology Program, Sirius University of Science and Technology, Sochi, Russia
| | - Vadim S Nikitin
- Neurobiology Program, Sirius University of Science and Technology, Sochi, Russia
| | - Anton D Shevlyakov
- Neurobiology Program, Sirius University of Science and Technology, Sochi, Russia
| | - Aleksey N Ikrin
- Neurobiology Program, Sirius University of Science and Technology, Sochi, Russia
| | - Radmir R Mukhamadeev
- Neurobiology Program, Sirius University of Science and Technology, Sochi, Russia
| | | | - Kirill V Apukhtin
- Neurobiology Program, Sirius University of Science and Technology, Sochi, Russia
| | | | - Nikita P Ilyin
- Institute of Experimental Medicine, Almazov National Medical Research Centre, Ministry of Healthcare of Russian Federation, St. Petersburg, Russia
- Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia
| | - Murilo S de Abreu
- Western Caspian University, Baku, Azerbaijan.
- Graduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil.
| | - Konstantin A Demin
- Institute of Experimental Medicine, Almazov National Medical Research Centre, Ministry of Healthcare of Russian Federation, St. Petersburg, Russia
- Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia
| | - Allan V Kalueff
- Neurobiology Program, Sirius University of Science and Technology, Sochi, Russia.
- Institute of Experimental Medicine, Almazov National Medical Research Centre, Ministry of Healthcare of Russian Federation, St. Petersburg, Russia.
- Department of Biosciences and Bioinformatics, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China.
- Suzhou Municipal Key Laboratory of Neurobiology and Cell Signaling, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China.
| |
Collapse
|
5
|
Cui J, Li H, Hu C, Zhang F, Li Y, Weng Y, Yang L, Li Y, Yao M, Li H, Luo X, Hao Y. Unraveling pathogenesis and potential biomarkers for autism spectrum disorder associated with HIF1A pathway based on machine learning and experiment validation. Neurobiol Dis 2025; 204:106763. [PMID: 39657846 DOI: 10.1016/j.nbd.2024.106763] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2024] [Revised: 10/05/2024] [Accepted: 12/04/2024] [Indexed: 12/12/2024] Open
Abstract
BACKGROUND Autism spectrum disorder (ASD) is a neurodevelopmental disorder with a high social burden and limited treatments. Hypoxic condition of the brain is considered an important pathological mechanism of ASD. HIF1A is a key participant in brain hypoxia, but its contribution to the pathophysiological landscape of ASD remains unclear. METHODS ASD-related datasets were obtained from GEO database, and HIF1A-related genes from GeneCards. Co-expression module analysis identified module genes, which were intersected with HIF1A-related genes to identify common genes. Machine learning identified hub genes from intersection genes and PPI networks were constructed to explore relationships among hub and HIF1A. Single-cell RNA sequencing analyzed hub gene distribution across cell clusters. ASD mouse model was created by inducing maternal immune activation (MIA) with poly(I:C) injections, verified through behavioral tests. Validation of HIF1A pathway and hub genes was confirmed through Western Blot, qPCR, and immunofluorescence in ASD mice and microglia BV-2 cells. RESULTS Using CEMiTool and GeneCards, 45 genes associated with ASD and HIF1A pathway were identified. Machine learning identified CDKN1A, ETS2, LYN, and SLC16A3 as potential ASD diagnostic markers. Single-cell sequencing pinpointed activated microglia as key immune cells. Behavioral tests showed MIA offspring mice exhibited typical ASD-like behaviors. Immunofluorescence confirmed the activation of microglia and HIF1A pathway in frontal cortex of ASD mice. Additionally, IL-6 contributed to ASD by activating JUN/HIF1A pathway, affecting CDKN1A, LYN, and SLC16A3 expression in microglia. CONCLUSIONS HIF1A-related genes CDKN1A, ETS2, LYN, and SLC16A3 are strong diagnostic markers for ASD and the activation of IL-6/JUN/HIF1A pathway in microglia contributes to the pathogenesis of ASD.
Collapse
Affiliation(s)
- Jinru Cui
- Division of Child Healthcare, Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - Heli Li
- Division of Child Healthcare, Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - Cong Hu
- Division of Child Healthcare, Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - Feiyan Zhang
- Division of Child Healthcare, Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - Yunjie Li
- Division of Child Healthcare, Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - Ying Weng
- Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - Liping Yang
- Division of Child Healthcare, Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - Yingying Li
- Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - Minglan Yao
- Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - Hao Li
- Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - Xiaoping Luo
- Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - Yan Hao
- Division of Child Healthcare, Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
| |
Collapse
|
6
|
Nekhoroshev EV, Kleshchev MA, Volgin AD, Shevlyakov AD, Bao X, Wang S, de Abreu MS, Amstislavskaya TG, Kalueff AV. Laser-Induced Olfactory Bulbectomy in Adult Zebrafish as a Novel Putative Model for Affective Syndrome: A Research Tribute to Brian Leonard. Eur J Neurosci 2025; 61:e16660. [PMID: 39804131 DOI: 10.1111/ejn.16660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2024] [Revised: 11/21/2024] [Accepted: 12/16/2024] [Indexed: 03/04/2025]
Abstract
Inducing multiple neurobehavioural and neurochemical deficits, olfactory bulbectomy (OBX) has been developed as a rodent model of depression with potential for antidepressant drug screening. However, the generality of this model in other vertebrate taxa remains poorly understood. A small freshwater teleost fish, the zebrafish (Danio rerio), is rapidly becoming a common model species in neuroscience research. Capitalizing on a recently developed model of noninvasive targeted laser ablation of zebrafish brain, here we report an OBX model in adult fish. An easy-to-perform noninvasive method of inducing affective syndrome-like behavioural deficits in fish, it extends the generality of OBX to other taxa beyond mammals, also offering several practical advantages and novel lines of research in experimental modelling of CNS disorders. The work is a scientific tribute to the legacy of Brian Leonard (1936-2023), a great friend and a brilliant scientist who introduced OBX as a rodent model for affective pathobiology and whose advice and encouragement have inspired the present study.
Collapse
Affiliation(s)
- Evgeny V Nekhoroshev
- Scientific Research Institute of Neurosciences and Medicine, Novosibirsk, Russia
| | - Maxim A Kleshchev
- Scientific Research Institute of Neurosciences and Medicine, Novosibirsk, Russia
| | - Andrey D Volgin
- Scientific Research Institute of Neurosciences and Medicine, Novosibirsk, Russia
| | - Anton D Shevlyakov
- Scientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, Federal Territory Sirius, Sirius, Russia
| | - Xixin Bao
- Scientific Research Institute of Neurosciences and Medicine, Novosibirsk, Russia
| | - Shenghao Wang
- Scientific Research Institute of Neurosciences and Medicine, Novosibirsk, Russia
| | - Murilo S de Abreu
- Graduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil
- Western Caspian University, Baku, Azerbaijan
| | | | - Allan V Kalueff
- Scientific Center for Genetics and Life Sciences, Sirius University of Science and Technology, Federal Territory Sirius, Sirius, Russia
- Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia
- Institute of Experimental Medicine, Almazov National Medical Research Center, St. Petersburg, Russia
- Department of Biosciences and Bioinformatics, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China
- Suzhou Municipal Key Laboratory of Neurobiology and Cell Signaling, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, China
| |
Collapse
|
7
|
Hillman C, Fontana BD, Amstislavskaya TG, Gorbunova MA, Altenhofen S, Barthelson K, Bastos LM, Borba JV, Bonan CD, Brennan CH, Farias-Cea A, Cooper A, Corcoran J, Dondossola ER, Martinez-Duran LM, Gallas-Lopes M, Galstyan DS, Garcia EO, Gerken E, Hindges R, Kenney JW, Kleshchev MA, Kolesnikova TO, Leggieri A, Khatsko SL, Lardelli M, Lodetti G, Lombardelli G, Luchiari AC, Portela SM, Medan V, Moutinho LM, Nekhoroshev EV, Petersen BD, Petrunich-Rutherford ML, Piato A, Porfiri M, Read E, Resmim CM, Rico EP, Rosemberg DB, de Abreu MS, Salazar CA, Stahloher-Buss T, Teixeira JR, Valentim AM, Zhdanov AV, Iturriaga-Vásquez P, Wang X, Wong RY, Kalueff AV, Parker MO. Housing and Husbandry Factors Affecting Zebrafish ( Danio rerio) Novel Tank Test Responses: A Global Multi-Laboratory Study. RESEARCH SQUARE 2024:rs.3.rs-4849877. [PMID: 39483890 PMCID: PMC11527349 DOI: 10.21203/rs.3.rs-4849877/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2024]
Abstract
The reproducibility crisis in bioscience, characterized by inconsistent study results, impedes our understanding of biological processes and global collaborative studies offer a unique solution. This study is the first global collaboration using the zebrafish (Danio rerio) novel tank test, a behavioral assay for anxiety-like responses. We analyzed data from 20 laboratories worldwide, focusing on housing conditions and experimental setups. Our study included 488 adult zebrafish, tested for 5 min, focusing on a variety of variables. Key findings show females exhibit more anxiety-like behavior than males, underscoring sex as a critical variable. Housing conditions, including higher stocking densities and specific feed types, influenced anxiety levels. Optimal conditions (5 fish/L) and nutritionally rich feeds (e.g., rotifers), mitigated anxiety-like behaviors. Environmental stressors, like noise and transportation, significantly impacted behavior. We recommend standardizing protocols to account for sex differences, optimal stocking densities, nutritionally rich feeds, and minimizing stressors to improve zebrafish behavioral study reliability.
Collapse
Affiliation(s)
- Courtney Hillman
- Surrey Sleep Research Centre, Department of Clinical and Experimental Medicine, School of Biosciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK
| | - Barbara D. Fontana
- Laboratory of Experimental Neuropsychobiology, Department of Biochemistry and Molecular Biology, Natural and Exact Sciences Center, Federal University of Santa Maria, Santa Maria, RS 97105-900, Brazil
- Department of Biological Sciences, Wayne State University, Detroit, Michigan, 48202, USA
| | - Tamara G. Amstislavskaya
- Laboratory of experimental models of neuropsychiatric disorders, Scientific Research Institute of Neurosciences and Medicine, Novosibirsk State University, Novosibirsk, Russia
| | | | - Stefani Altenhofen
- Laboratório de Neuroquímica e Psicofarmacologia, Escola de Ciências da Saúde e da Vida, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, 90619-900, Porto Alegre, RS, BR
| | - Karissa Barthelson
- Alzheimer’s Disease Genetics Laboratory, School of Biological Sciences, Faculty of Sciences, Engineering and Technology, The University of Adelaide, North Terrace Campus, Adelaide, SA, Australia 5005
- Childhood Dementia Research Group, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA 5042, Australia
| | - Leonardo M. Bastos
- Laboratório de Psicofarmacologia e Comportamento, Departamento de Farmacologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Ramiro Barcelos 2600, Porto Alegre, RS, 90035-003, Brazil
| | - João V. Borba
- Laboratory of Experimental Neuropsychobiology, Department of Biochemistry and Molecular Biology, Natural and Exact Sciences Center, Federal University of Santa Maria, Santa Maria, RS 97105-900, Brazil
| | - Carla D. Bonan
- Laboratório de Neuroquímica e Psicofarmacologia, Escola de Ciências da Saúde e da Vida, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, 90619-900, Porto Alegre, RS, BR
| | - Caroline H. Brennan
- School of Biological and Behavioural Sciences, Queen Mary University of London, London, E1 4NS, UK
| | - Amaury Farias-Cea
- Molecular Pharmacology and Medicinal Chemistry Lab, Facultad de Ingeniería y Ciencias, Universidad de la Frontera, Temuco, Chile
| | - Austin Cooper
- Surrey Sleep Research Centre, Department of Clinical and Experimental Medicine, School of Biosciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK
| | - Jamie Corcoran
- Department of Psychology, University of Nebraska at Omaha, Omaha, Nebraska, 68182 USA
| | - Eduardo R. Dondossola
- Translational Psychiatry Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, SC, Brazil
| | - Luis M. Martinez-Duran
- Molecular Pharmacology and Medicinal Chemistry Lab, Facultad de Ingeniería y Ciencias, Universidad de la Frontera, Temuco, Chile
| | - Matheus Gallas-Lopes
- Laboratório de Psicofarmacologia e Comportamento, Departamento de Farmacologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Ramiro Barcelos 2600, Porto Alegre, RS, 90035-003, Brazil
| | | | - Ella O. Garcia
- Department of Psychology, Indiana University Northwest, Gary, Indiana, 46408, USA
| | - Ewan Gerken
- Alzheimer’s Disease Genetics Laboratory, School of Biological Sciences, Faculty of Sciences, Engineering and Technology, The University of Adelaide, North Terrace Campus, Adelaide, SA, Australia 5005
| | - Robert Hindges
- Centre for Developmental Neurobiology & MRC Centre for Neurodevelopmental Disorders, King’s College London, London, England, UK
| | - Justin W. Kenney
- Department of Biological Sciences, Wayne State University, Detroit, Michigan, 48202, USA
| | - Maxim A. Kleshchev
- Laboratory of experimental models of neuropsychiatric disorders, Scientific Research Institute of Neurosciences and Medicine, Novosibirsk State University, Novosibirsk, Russia
| | | | - Adele Leggieri
- School of Biological and Behavioural Sciences, Queen Mary University of London, London, E1 4NS, UK
| | | | - Michael Lardelli
- Alzheimer’s Disease Genetics Laboratory, School of Biological Sciences, Faculty of Sciences, Engineering and Technology, The University of Adelaide, North Terrace Campus, Adelaide, SA, Australia 5005
| | - Guilherme Lodetti
- Translational Psychiatry Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, SC, Brazil
| | - Giulia Lombardelli
- Department of Mechanical and Aerospace Engineering, Department of Biomedical Engineering, Center for Urban Science and Progress, New York University, Tandon School of Engineering, New York, 11201, USA
| | - Ana C. Luchiari
- FishLab, Department of Physiology and Behavior, Federal University of Rio Grande do Norte, Natal, Brazil
| | - Stefani M. Portela
- Laboratório de Psicofarmacologia e Comportamento, Departamento de Farmacologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Ramiro Barcelos 2600, Porto Alegre, RS, 90035-003, Brazil
| | - Violeta Medan
- Instituto de Fisiología, Biología Molecular y Neurociencias, Consejo Nacional de Investigaciones Científicas y Tecnológicas. Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina
| | - Lirane M. Moutinho
- Instituto de Fisiología, Biología Molecular y Neurociencias, Consejo Nacional de Investigaciones Científicas y Tecnológicas. Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina
| | - Evgeny V. Nekhoroshev
- Laboratory of experimental models of neuropsychiatric disorders, Scientific Research Institute of Neurosciences and Medicine, Novosibirsk State University, Novosibirsk, Russia
| | - Barbara D. Petersen
- Laboratório de Neuroquímica e Psicofarmacologia, Escola de Ciências da Saúde e da Vida, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, 90619-900, Porto Alegre, RS, BR
| | | | - Angelo Piato
- Laboratório de Psicofarmacologia e Comportamento, Departamento de Farmacologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Ramiro Barcelos 2600, Porto Alegre, RS, 90035-003, Brazil
| | - Maurizio Porfiri
- Department of Mechanical and Aerospace Engineering, Department of Biomedical Engineering, Center for Urban Science and Progress, New York University, Tandon School of Engineering, New York, 11201, USA
| | - Emily Read
- Centre for Developmental Neurobiology & MRC Centre for Neurodevelopmental Disorders, King’s College London, London, England, UK
| | - Cássio M. Resmim
- Laboratory of Experimental Neuropsychobiology, Department of Biochemistry and Molecular Biology, Natural and Exact Sciences Center, Federal University of Santa Maria, Santa Maria, RS 97105-900, Brazil
| | - Eduardo P. Rico
- Translational Psychiatry Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, SC, Brazil
| | - Denis B. Rosemberg
- Laboratory of Experimental Neuropsychobiology, Department of Biochemistry and Molecular Biology, Natural and Exact Sciences Center, Federal University of Santa Maria, Santa Maria, RS 97105-900, Brazil
| | - Murilo S. de Abreu
- Graduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil
- Western Caspian University, Baku, Azerbaijan
- The International Zebrafish Neuroscience Research Consortium (ZNRC), Slidell, LA 70458, USA
| | - Catia A. Salazar
- Department of Psychology, Indiana University Northwest, Gary, Indiana, 46408, USA
| | - Thaliana Stahloher-Buss
- Laboratório de Psicofarmacologia e Comportamento, Departamento de Farmacologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Ramiro Barcelos 2600, Porto Alegre, RS, 90035-003, Brazil
| | - Júlia R. Teixeira
- FishLab, Department of Physiology and Behavior, Federal University of Rio Grande do Norte, Natal, Brazil
| | - Ana M. Valentim
- Laboratory Animal Science, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, (i3S), 4200-135 Porto, Portugal
| | | | - Patricio Iturriaga-Vásquez
- Molecular Pharmacology and Medicinal Chemistry Lab, Facultad de Ingeniería y Ciencias, Universidad de la Frontera, Temuco, Chile
| | - Xian Wang
- School of Biological and Behavioural Sciences, Queen Mary University of London, London, E1 4NS, UK
| | - Ryan Y. Wong
- Department of Psychology, University of Nebraska at Omaha, Omaha, Nebraska, 68182 USA
- Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska, 68182 USA
| | - Allan V. Kalueff
- Laboratory of experimental models of neuropsychiatric disorders, Scientific Research Institute of Neurosciences and Medicine, Novosibirsk State University, Novosibirsk, Russia
- St. Petersburg State University, St. Petersburg, Russia
- Neurobiology Program, Sirius University of Science and Technology, Sochi, Russia
- Western Caspian University, Baku, Azerbaijan
| | - Matthew O. Parker
- Surrey Sleep Research Centre, Department of Clinical and Experimental Medicine, School of Biosciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK
| |
Collapse
|
8
|
Katchur NJ, Notterman DA. Recent insights from non-mammalian models of brain injuries: an emerging literature. Front Neurol 2024; 15:1378620. [PMID: 38566857 PMCID: PMC10985199 DOI: 10.3389/fneur.2024.1378620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2024] [Accepted: 02/26/2024] [Indexed: 04/04/2024] Open
Abstract
Traumatic brain injury (TBI) is a major global health concern and is increasingly recognized as a risk factor for neurodegenerative diseases including Alzheimer's disease (AD) and chronic traumatic encephalopathy (CTE). Repetitive TBIs (rTBIs), commonly observed in contact sports, military service, and intimate partner violence (IPV), pose a significant risk for long-term sequelae. To study the long-term consequences of TBI and rTBI, researchers have typically used mammalian models to recapitulate brain injury and neurodegenerative phenotypes. However, there are several limitations to these models, including: (1) lengthy observation periods, (2) high cost, (3) difficult genetic manipulations, and (4) ethical concerns regarding prolonged and repeated injury of a large number of mammals. Aquatic vertebrate model organisms, including Petromyzon marinus (sea lampreys), zebrafish (Danio rerio), and invertebrates, Caenorhabditis elegans (C. elegans), and Drosophila melanogaster (Drosophila), are emerging as valuable tools for investigating the mechanisms of rTBI and tauopathy. These non-mammalian models offer unique advantages, including genetic tractability, simpler nervous systems, cost-effectiveness, and quick discovery-based approaches and high-throughput screens for therapeutics, which facilitate the study of rTBI-induced neurodegeneration and tau-related pathology. Here, we explore the use of non-vertebrate and aquatic vertebrate models to study TBI and neurodegeneration. Drosophila, in particular, provides an opportunity to explore the longitudinal effects of mild rTBI and its impact on endogenous tau, thereby offering valuable insights into the complex interplay between rTBI, tauopathy, and neurodegeneration. These models provide a platform for mechanistic studies and therapeutic interventions, ultimately advancing our understanding of the long-term consequences associated with rTBI and potential avenues for intervention.
Collapse
Affiliation(s)
- Nicole J. Katchur
- Department of Molecular Biology, Princeton University, Princeton, NJ, United States
- Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ, United States
| | - Daniel A. Notterman
- Department of Molecular Biology, Princeton University, Princeton, NJ, United States
| |
Collapse
|
9
|
Mariën V, Arckens L, Van Houcke J. A Robust and Reproducible Method to Study Neurorepair after Stab Injury in the African Turquoise Killifish Telencephalon. Cold Spring Harb Protoc 2024; 2024:107809. [PMID: 36921997 DOI: 10.1101/pdb.prot107809] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/18/2023]
Abstract
The aging population (people >60 yr old) is steadily increasing worldwide, resulting in an increased prevalence of age-related neurodegenerative diseases. Despite intensive research efforts in the past decades, there are still no therapies available to stop, cure, or prevent these diseases. Induction of successful neuroregeneration (i.e., the production of new neurons that can functionally integrate into the existing neural circuitry) could represent a therapy to replace neurons lost by injury or disease in the aged central nervous system. The African turquoise killifish, with its particularly short life span, has emerged as a useful model to study how aging influences neuroregeneration. Here, we describe a robust and reproducible stab-injury protocol to study regeneration in the telencephalon of the African turquoise killifish. After the injury, newborn cells are traced by conducting a BrdU pulse-chase experiment. To identify newborn neurons, a double immunohistochemical staining for BrdU and HuCD is carried out. Techniques such as bromodeoxyuridine (BrdU) labeling, intracardial perfusion, cryosectioning, and immunofluorescence staining are described as separate sections.
Collapse
Affiliation(s)
- Valerie Mariën
- Neuroplasticity and Neuroproteomics Research Group, Animal Physiology and Neurobiology Section, Department of Biology, KU Leuven, 3000, Leuven, Belgium
| | - Lutgarde Arckens
- Neuroplasticity and Neuroproteomics Research Group, Animal Physiology and Neurobiology Section, Department of Biology, KU Leuven, 3000, Leuven, Belgium
| | - Jolien Van Houcke
- Neuroplasticity and Neuroproteomics Research Group, Animal Physiology and Neurobiology Section, Department of Biology, KU Leuven, 3000, Leuven, Belgium
| |
Collapse
|